-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/Kenyon2014.pdf
February 01, 2014 - Rehospitalization for Childhood Asthma: Timing, Variation, and Opportunities for Intervention
Rehospitalization for Childhood Asthma: Timing, Variation, and
Opportunities for Intervention
Ch�en C. Kenyon, MD1,2, Patrice R. Melvin, MPH3, Vincent W. Chiang, MD2,4, Marc N. Elliott, PhD5,
Mark A. Schuster, MD, PhD2,4, …
-
www.monahrq.ahrq.gov/chsp/publications/index.html
September 01, 2023 - Skip to main content
An official website of the Department of Health and Human Services
Careers
Contact Us
Español
FAQs
Search all AHRQ sites
Search small
Search
Menu
…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/CHIPRA0087-NCINQSexualActivityStatusForm.pdf
February 06, 2012 - chronic conditions across the sites were: 1)
asthma; 2) depression; 3) attention deficient hyperactivity disorder
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/NCINQTobaccoUseHelpForm.pdf
August 01, 2012 - chronic conditions across the sites were: 1) asthma;
2) depression; 3) attention deficient hyperactivity disorder
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/cpcf.pdf
December 31, 2015 - CHIPRA Pediatric Quality Measures Program (PQMP) Candidate Measure Submission Form (CPCF)
CHIPRA Pediatric Quality Measures
Program (PQMP) Candidate Measure
Submission Form (CPCF)
The CHIPRA Pediatric Quality Measures Program (PQMP) Candidate Measure Submission
Form (CPCF) was approved by the Office of Manage…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/meta/meta-analyses-refs.pdf
January 01, 2007 - Treating Tobacco Use and Dependence, 2008 Update: References for Studies in Meta-analyses
1
References for Studies Included in Meta-analyses
Table 6.4. Meta-analysis (1996): Impact of
having a tobacco use status identification
system in place on rates of clinician
intervention with their patients who smoke (n…
-
www.monahrq.ahrq.gov/patient-safety/resources/learning-lab/index.html
February 01, 2024 - (This process will be studied in children with autism spectrum disorder on antipsychotics.)
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/research/findings/ta/topicrefinement/liquid-biopsy-topicrefinement.pdf
July 29, 2021 - Final Topic Refinement Document - Role of Liquid Biopsy in Detection and Management of Cancer in the Medicare Population
1
Final Topic Refinement Document
Role of Liquid Biopsy in Detection and Management of Cancer
in the Medicare Population
ID: MYOE58
Agency for Healthcare Research and Quality
Te…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023qdr-data-sources.pdf
December 01, 2023 - 2023 National Healthcare Quality and Disparities Report Data Sources
2023 National Healthcare Quality and
Disparities Report
Data Sources
U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/pubs/background-2012/backgrnd2012.pdf
January 01, 2012 - Key: ADHD = attention deficit/hyperactivity disorder; AHRQ = Agency for Healthcare Research and Quality
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-factors-influencing-state-reporting.pdf
July 01, 2016 - • m
Follow-up care for children prescribed attention-deficit/hyperactivity Administrative m • • •
disorder
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/chipra-primary-care-physician-reporting.pdf
December 01, 2016 - department
visits for asthma, and medication follow-up visits for attention deficit-hyperactivity disorder
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-209-fullreport.pdf
June 01, 2019 - interventions, as well as an increased relative risk of developing attention deficit
hyperactivity disorder
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/long-term-care/resources/ontime/fallsprev/ontimefallpxreports-ig.pdf
November 09, 2017 - hemiparesis
o Paraplegia
o Multiple sclerosis
o Huntington’s disease
o Parkinson’s disease
o Seizure disorder
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-155-section-6-b-measure.pdf
January 01, 2013 - CHIPRA 155: Section 6.B, Scientific Soundness of the Measure
SECTION VI.
SCIENTIFIC SOUNDNESS OF THE MEASURE
VI.B. Validity
VI.B.1 Construct Validity
To examine construct validity, we performed compara…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-fullreport.pdf
April 01, 2019 - o Blood disorder.
-
www.monahrq.ahrq.gov/sites/default/files/publications/files/casalino_idkeydsr.pdf
February 01, 2014 - Identifying Key Areas for Delivery System Research
Identifying Key Areas for Delivery System Research
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.gov
Work for this paper was conducte…
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-0087-fullreport.pdf
October 01, 2016 - conditions across the sites were: (1) asthma; (2) depression; (3) attention
deficient hyperactivity disorder
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-156-section-6b.pdf
January 01, 2013 - not associated with improved follow-up for children diagnosed with
attention-deficit hyperactivity disorder
-
www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-0090-fullreport.pdf
July 25, 2016 - conditions across the sites were: (1) asthma; (2) depression; (3) attention
deficient hyperactivity disorder